In our study, we also identified an AKAP12-related immunomodulator signature for STAD prognosis prediction, in which four immunomodulators (CXCR4, IL6, NT5E, and TNFSF18) were included. The gene discussed is CXCR4; the disease is gastric adenocarcinoma.